These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 12716529)

  • 1. [Immunization and problems of newborns receiving hepatitis B vaccines in countryside].
    Li RC
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):241. PubMed ID: 12716529
    [No Abstract]   [Full Text] [Related]  

  • 2. Age at presentation for infant immunization in Nigeria: implications for hepatitis B immunization.
    Sadoh AE; Eregie CO
    Public Health; 2008 Dec; 122(12):1318-20. PubMed ID: 18706664
    [No Abstract]   [Full Text] [Related]  

  • 3. Benefits of early hepatitis B immunization programs for newborns and infants.
    Van Herck K; Van Damme P
    Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the quebec school-based hepatitis B immunization program and potential benefit of the addition of an infant immunization program.
    Gîlca V; Duval B; Boulianne N; Dion R; De Serres G
    Pediatr Infect Dis J; 2006 Apr; 25(4):372-4. PubMed ID: 16567995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global progress toward universal childhood hepatitis B vaccination, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(36):868-70. PubMed ID: 12970620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis B vaccination].
    Zhang H
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):197-8. PubMed ID: 12716509
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatitis B vaccine in patients with human immunodeficiency virus infection].
    Ramírez O CA; Fernández A DG; Valderrama B SL; Gómez Q CH; Támara R JR; Alvarez M CA
    Rev Chilena Infectol; 2009 Feb; 26(1):26-33. PubMed ID: 19350156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum level of anti-hepatitis B surface antigen 6-8 years after hepatitis B vaccination at birth.
    Kazemi A; Koosha A; Rafizadeh B; Mousavinasab N; Mahram M
    East Mediterr Health J; 2008; 14(4):960-5. PubMed ID: 19166180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B vaccination in the expanded programme of immunization.
    Mittal SK; Aggarwal V
    Trop Gastroenterol; 1996; 17(3):188-90. PubMed ID: 8987417
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vaccination. Hepatitis B].
    Braun R; Kimmig P; Hassler D
    Dtsch Med Wochenschr; 2002 May; 127(20):1062. PubMed ID: 12051190
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adjustment of the hepatitis-B vaccination scheme for newborns born to hepatitis-B virus carriers as of 1 January 2006].
    Geelen SP
    Ned Tijdschr Geneeskd; 2006 Feb; 150(8):415-8. PubMed ID: 16538839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
    Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
    Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The global impact of vaccination against hepatitis B: a historical overview.
    Zanetti AR; Van Damme P; Shouval D
    Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A nested case control study for risk factors impacting hepatitis B vaccination in Hebei, China].
    Ma JC; Han CZ; Qi SX; Tian C; Li J; Zhao SJ; Zhang Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):201-4. PubMed ID: 19031703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing serological status and low vaccination-induced protection rates against hepatitis B characterize chronic hepatitis C virus-infected injecting drug users in Greece: need for immunization policy.
    Elefsiniotis IS; Pantazis KD; Ketikoglou ID; Koutsounas SI; Tsianos EV
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1227-31. PubMed ID: 17033445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of concurrent use of hepatitis B and Bacille Calmette-Guérin vaccination on anti-hepatitis B response.
    Artan R; Erol M; Velipasaoglu S; Yegin O
    Saudi Med J; 2004 Dec; 25(12):1939-42. PubMed ID: 15711671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical efficacy and immunologic responses of hepatitis B vaccination in very-low-birth-weight infants.
    Yang YJ; Lin CH; Tai YT; Huang SC; Lin YJ
    Pediatr Infect Dis J; 2008 Aug; 27(8):768. PubMed ID: 18574432
    [No Abstract]   [Full Text] [Related]  

  • 19. [Protection of children born to hepatitis-B-infected mothers].
    Boot HJ; Vermeer-de Bondt PE; Kimman TG
    Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1816-8. PubMed ID: 15495509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B surface antibody response of household contacts of hepatitis B virus carriers in Palestine.
    Adwan K; Abu-Hasan N; Adwan G; Abu-Khater K
    East Mediterr Health J; 2005 May; 11(3):494-8. PubMed ID: 16602472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.